David Tischler

David Tischler is an experienced professional in the life sciences sector, currently engaged in consultancy through Tischler BioConsulting since February 2019, focusing on financing and business development for therapeutics and TechBio companies. Tischler currently serves as an advisor and consultant for prominent firms, including Aviko Radiopharmaceuticals and Apertura Gene Therapy, contributing to innovative therapeutic solutions in oncology and gene therapy. Previously, Tischler co-founded ZetaGen Therapeutics, leading its development in regenerative medicine and oncology, and held key positions at Castlight Health and DigiSight Technologies. Tischler's educational background includes an MBA from the University of California, Berkeley, a BS in Biology from the University of Michigan, and a SIGM from Stanford University.